246 related articles for article (PubMed ID: 17545591)
21. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.
Wei M; Grushko TA; Dignam J; Hagos F; Nanda R; Sveen L; Xu J; Fackenthal J; Tretiakova M; Das S; Olopade OI
Cancer Res; 2005 Dec; 65(23):10692-9. PubMed ID: 16322213
[TBL] [Abstract][Full Text] [Related]
22. The XIST noncoding RNA functions independently of BRCA1 in X inactivation.
Xiao C; Sharp JA; Kawahara M; Davalos AR; Difilippantonio MJ; Hu Y; Li W; Cao L; Buetow K; Ried T; Chadwick BP; Deng CX; Panning B
Cell; 2007 Mar; 128(5):977-89. PubMed ID: 17350580
[TBL] [Abstract][Full Text] [Related]
23. Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors.
Joosse SA; Brandwijk KI; Mulder L; Wesseling J; Hannemann J; Nederlof PM
Genes Chromosomes Cancer; 2011 Feb; 50(2):71-81. PubMed ID: 21104783
[TBL] [Abstract][Full Text] [Related]
24. Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH.
Joosse SA; van Beers EH; Tielen IH; Horlings H; Peterse JL; Hoogerbrugge N; Ligtenberg MJ; Wessels LF; Axwijk P; Verhoef S; Hogervorst FB; Nederlof PM
Breast Cancer Res Treat; 2009 Aug; 116(3):479-89. PubMed ID: 18704682
[TBL] [Abstract][Full Text] [Related]
25. X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status.
Looijenga LH; Gillis AJ; van Gurp RJ; Verkerk AJ; Oosterhuis JW
Am J Pathol; 1997 Aug; 151(2):581-90. PubMed ID: 9250171
[TBL] [Abstract][Full Text] [Related]
26. Estrogen receptor status could modulate the genomic pattern in familial and sporadic breast cancer.
Melchor L; Honrado E; Huang J; Alvarez S; Naylor TL; García MJ; Osorio A; Blesa D; Stratton MR; Weber BL; Cigudosa JC; Rahman N; Nathanson KL; Benítez J
Clin Cancer Res; 2007 Dec; 13(24):7305-13. PubMed ID: 18094411
[TBL] [Abstract][Full Text] [Related]
27. Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines.
Benoît MH; Hudson TJ; Maire G; Squire JA; Arcand SL; Provencher D; Mes-Masson AM; Tonin PN
Int J Oncol; 2007 Jan; 30(1):5-17. PubMed ID: 17143508
[TBL] [Abstract][Full Text] [Related]
28. Incidence of numerical chromosome aberrations in meningioma tumors as revealed by fluorescence in situ hybridization using 10 chromosome-specific probes.
Sayagués JM; Tabernero MD; Maillo A; Díaz P; Rasillo A; Bortoluci A; Gomez-Moreta J; Santos-Briz A; Morales F; Orfao A
Cytometry; 2002 Jun; 50(3):153-9. PubMed ID: 12116338
[TBL] [Abstract][Full Text] [Related]
29. A proximal conserved repeat in the Xist gene is essential as a genomic element for X-inactivation in mouse.
Hoki Y; Kimura N; Kanbayashi M; Amakawa Y; Ohhata T; Sasaki H; Sado T
Development; 2009 Jan; 136(1):139-46. PubMed ID: 19036803
[TBL] [Abstract][Full Text] [Related]
30. Misbehaviour of XIST RNA in breast cancer cells.
Sirchia SM; Tabano S; Monti L; Recalcati MP; Gariboldi M; Grati FR; Porta G; Finelli P; Radice P; Miozzo M
PLoS One; 2009; 4(5):e5559. PubMed ID: 19440381
[TBL] [Abstract][Full Text] [Related]
31. A transient heterochromatic state in Xist preempts X inactivation choice without RNA stabilization.
Sun BK; Deaton AM; Lee JT
Mol Cell; 2006 Mar; 21(5):617-28. PubMed ID: 16507360
[TBL] [Abstract][Full Text] [Related]
32. Incomplete X-inactivation initiated by a hypomorphic Xist allele in the mouse.
Hoki Y; Ikeda R; Mise N; Sakata Y; Ohhata T; Sasaki H; Abe K; Sado T
Development; 2011 Jul; 138(13):2649-59. PubMed ID: 21613321
[TBL] [Abstract][Full Text] [Related]
33. Identification of the chromatin regions coated by non-coding Xist RNA.
Murakami K; Ohhira T; Oshiro E; Qi D; Oshimura M; Kugoh H
Cytogenet Genome Res; 2009; 125(1):19-25. PubMed ID: 19617692
[TBL] [Abstract][Full Text] [Related]
34. Chromosome 22 array-CGH profiling of breast cancer delimited minimal common regions of genomic imbalances and revealed frequent intra-tumoral genetic heterogeneity.
Benetkiewicz M; Piotrowski A; Díaz De Ståhl T; Jankowski M; Bala D; Hoffman J; Srutek E; Laskowski R; Zegarski W; Dumanski JP
Int J Oncol; 2006 Oct; 29(4):935-45. PubMed ID: 16964389
[TBL] [Abstract][Full Text] [Related]
35. Evidence for de novo imprinted X-chromosome inactivation independent of meiotic inactivation in mice.
Okamoto I; Arnaud D; Le Baccon P; Otte AP; Disteche CM; Avner P; Heard E
Nature; 2005 Nov; 438(7066):369-73. PubMed ID: 16227973
[TBL] [Abstract][Full Text] [Related]
36. Expression and function of a large non-coding RNA gene XIST in human cancer.
Weakley SM; Wang H; Yao Q; Chen C
World J Surg; 2011 Aug; 35(8):1751-6. PubMed ID: 21212949
[TBL] [Abstract][Full Text] [Related]
37. Chromosomal aberrations involving telomeres in BRCA1 deficient human and mouse cell lines.
Al-Wahiby S; Slijepcevic P
Cytogenet Genome Res; 2005; 109(4):491-6. PubMed ID: 15905643
[TBL] [Abstract][Full Text] [Related]
38. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.
Melchor L; Honrado E; García MJ; Alvarez S; Palacios J; Osorio A; Nathanson KL; Benítez J
Oncogene; 2008 May; 27(22):3165-75. PubMed ID: 18071313
[TBL] [Abstract][Full Text] [Related]
39. The molecular pathology of hereditary breast cancer.
Palacios J; Robles-Frías MJ; Castilla MA; López-García MA; Benítez J
Pathobiology; 2008; 75(2):85-94. PubMed ID: 18544963
[TBL] [Abstract][Full Text] [Related]
40. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
